Navigating AI in Pharmacy: What We're Building at MedSpotter Canada

Navigating AI in Pharmacy: What We're Building at MedSpotter Canada

AI is transforming healthcare — but in pharmacy practice, it raises real questions: How do we keep AI transparent? Equitable? Respectful of patient autonomy?

At MedSpotter Canada, we're building our answer into the product, not just the policy page.

Transparency First

Our report confidence scoring doesn't hide behind a black-box number. Every "high confidence" or "unconfirmed" badge comes with a plain-language reason — confirmed by other users, reported by a verified pharmacy, or just recent. Patients and pharmacies should always know why they're seeing what they're seeing.

Prediction Without Overreach

We're rolling out early shortage-risk signals based on community reporting trends and official Health Canada data — but we're explicit that this is a community-data estimate, not clinical guidance. AI can flag a pattern; it shouldn't replace a pharmacist's judgment or a patient's choice.

Equity as a Design Constraint

Our data comes disproportionately from early-adopter regions right now. That's a real limitation — one we're tracking as we expand, because a shortage-prediction tool is only as fair as the data feeding it.

Data Security by Design

Any pattern detection we build works off aggregated, de-identified data — never raw user-level activity — in line with privacy frameworks like Quebec's Law 25.

The promise of AI in pharmacy — better decision support, fewer adverse events, smarter systems — only holds if it's built with these questions answered upfront, not patched in after the fact. That's the bar we're building MedSpotter to meet.